Research location
Frome
United Kingdom
Advertisement
Research activity in Frome
United KingdomCureCurrent currently publishes aggregate city-level research activity for this location: 16 trials and 16 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Frome
16 linked trials · page 1 of 1BI 10773 (Empagliflozin) Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients (EMPA-REG OUTCOME).NCT01131676 · 2010-07-01 · 1 site observation
COMPLETED
Efficacy and Safety of Empagliflozin (BI 10773) in Patients With Type 2 Diabetes and Renal ImpairmentNCT01164501 · 2010-07-01 · 1 site observation
COMPLETED
Comparison of Tiotropium in the HandiHaler Versus the Respimat in Chronic Obstructive Pulmonary DiseaseNCT01126437 · 2010-05-01 · 1 site observation
COMPLETED
European Study of Cardiovascular RiskNCT00882336 · 2009-05-01 · 1 site observation
COMPLETED
Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4)NCT00676338 · 2008-11-01 · 1 site observation
COMPLETED
Tiotropium Once Daily 18 Mcg Versus Salmeterol Twice Daily 50 Mcg on Time to First Exacerbation in COPD Patients.NCT00563381 · 2008-01-01 · 1 site observation
COMPLETED
A Study of Dipeptidyl-peptidase IV (DPP-IV) RO4876904 in Patients With Type 2 Diabetes.NCT00502710 · 2007-07-01 · 1 site observation
COMPLETED
Local Phase 4 Pan-European SMART StudyNCT00463866 · 2007-03-01 · 1 site observation
COMPLETED
Exenatide Versus Glimepiride in Patients With Type 2 DiabetesNCT00359762 · 2006-09-01 · 1 site observation
COMPLETED
Tiotropium / Respimat One Year Study in COPD.NCT00387088 · 2006-09-01 · 1 site observation
COMPLETED
To Compare the Effect of Liraglutide When Given Together With Metformin With the Effect of Metformin Given Alone and With the Effect of Glimepiride and Metformin Given TogetherNCT00318461 · 2006-05-01 · 1 site observation
COMPLETED
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of MetforminNCT00266253 · 2005-11-01 · 1 site observation
COMPLETED
Study to Evaluate the Efficacy and Safety of SLV306 in Subjects With HypertensionNCT00160212 · 2004-12-01 · 1 site observation
COMPLETED
Fenofibrate in Dyslipidemia and Metformin-Controlled DiabetesNCT00349128 · 2004-01-01 · 1 site observation
COMPLETED
Prospective Randomised Investigation of the Safety and Efficacy of Micardis® vs Ramipril Using ABPMNCT00274612 · 2002-10-01 · 1 site observation
COMPLETED
Effect of Liraglutide as add-on to Metformin Compared to Either Liraglutide or Metformin Alone, or to a Combination of Metformin and a SU (Sulphonylurea) Agent in Subjects With Type 2 DiabetesNCT01511172 · 2002-08-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.